Brandywine Global Investment Management LLC purchased a new stake in LifePoint Health, Inc. (NASDAQ:LPNT) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 114,551 shares of the company’s stock, valued at approximately $7,693,000. Brandywine Global Investment Management LLC owned 0.29% of LifePoint Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in LPNT. Teacher Retirement System of Texas grew its stake in LifePoint Health by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock worth $216,000 after purchasing an additional 9 shares in the last quarter. US Bancorp DE increased its holdings in LifePoint Health by 0.8% during the 2nd quarter. US Bancorp DE now owns 1,947 shares of the company’s stock worth $130,000 after purchasing an additional 16 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in LifePoint Health by 1.0% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,891 shares of the company’s stock worth $396,000 after purchasing an additional 56 shares during the period. Meeder Asset Management Inc. raised its position in LifePoint Health by 0.6% during the 2nd quarter. Meeder Asset Management Inc. now owns 13,547 shares of the company’s stock valued at $909,000 after purchasing an additional 76 shares in the last quarter. Finally, Mason Street Advisors LLC raised its position in LifePoint Health by 0.7% during the 1st quarter. Mason Street Advisors LLC now owns 18,870 shares of the company’s stock valued at $1,236,000 after purchasing an additional 128 shares in the last quarter. Hedge funds and other institutional investors own 99.53% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/03/brandywine-global-investment-management-llc-purchases-shares-of-114551-lifepoint-health-inc-lpnt.html.

In related news, Chairman William F. Carpenter III sold 17,653 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the sale, the chairman now directly owns 439,841 shares in the company, valued at $28,616,055.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 8.76% of the company’s stock.

Shares of LifePoint Health, Inc. (NASDAQ LPNT) opened at 58.65 on Tuesday. The firm’s 50 day moving average is $56.97 and its 200 day moving average is $61.41. LifePoint Health, Inc. has a 52-week low of $50.60 and a 52-week high of $70.95. The stock has a market capitalization of $2.35 billion, a price-to-earnings ratio of 13.13 and a beta of 0.84.

LifePoint Health (NASDAQ:LPNT) last released its earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the firm posted $0.69 EPS. LifePoint Health’s revenue for the quarter was up .2% on a year-over-year basis. Equities analysts expect that LifePoint Health, Inc. will post $4.06 earnings per share for the current year.

LPNT has been the subject of several research reports. BidaskClub cut LifePoint Health from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Zacks Investment Research downgraded LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, September 5th. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Royal Bank Of Canada restated a “buy” rating and set a $77.00 price target on shares of LifePoint Health in a research note on Wednesday, July 5th. Finally, Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $73.00 to $74.00 in a report on Tuesday, June 6th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $66.00.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.